ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,267, issued on March 17, was assigned to Glenmark Speciality S.A. (La Chaux-de-Fonds, Switzerland).

"Pyrimidine compounds for use as MAP4K1 inhibitors" was invented by Pravin Iyer (Navi Mumbai, India), Sanjib Das (Navi Mumbai, India), Murugan Chinnapattu (Navi Mumbai, India), Sachin Chaudhari (Navi Mumbai, India), Jagmohan Saini (Navi Mumbai, India), Sravan Mandadi (Navi Mumbai, India), Nagaraj Gowda (Navi Mumbai, India), Dnyaneshwar Dahale (Navi Mumbai, India), Sandip Patil (Navi Mumbai, India), Nanasaheb Kadlag (Navi Mumbai, India), Chandrasekhar Misra (Navi Mumbai, India) and Priyanka Pangare (Navi Mumbai, India).

According to the abstract* released by the U.S. Patent & Trade...